BI 2536 is under investigation in clinical trial NCT00376623 (Efficacy and Safety of BI 2536 in Advanced or Metastatic Non Small Cell Lung Cancer).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.